Kornitzer Capital Management Inc Organon & Co. Transaction History

Kornitzer Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$31.66 - $38.9 $1.07 Million - $1.31 Million	-33,742 Closed	0 $0
Q1 2022 Apr 27, 2022	SELL	$30.45 - $39.36 $71,527 - $92,456	-2,349 Reduced 6.51%	33,742 $1.18 Million
Q4 2021 Feb 01, 2022	SELL	$28.67 - $37.13 $65,596 - $84,953	-2,288 Reduced 5.96%	36,091 $1.1 Million
Q3 2021 Nov 03, 2021	SELL	$28.63 - $35.64 $157,092 - $195,556	-5,487 Reduced 12.51%	38,379 $1.26 Million
Q2 2021 Jul 30, 2021	BUY	$28.45 - $38.0 $1.25 Million - $1.67 Million	43,866 New	43,866 $1.33 Million

795

191M

1.59M

931K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.88B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

Stay updated on Kornitzer Capital Management Inc with notifications on news.